
Opinion|Videos|July 15, 2024
Hidradenitis Suppurativa (HS): Staging Considerations and Unmet Needs
Author(s)Vivian Shi, MD, FAAD
An expert on hidradenitis suppurativa (HS) provides an overview of the Hurley staging system and discusses unmet needs in the overall treatment landscape.
Advertisement
Video content above is prompted by the following questions:
- How does current treatment of HS correlate to the Hurley staging system?
- What are the unmet needs for the treatment of HS?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Real-World Data Support Dual Benefit of Biologic Therapy for Hidradenitis Suppurativa
2
The Ongoing Debate Over E-Cigarettes and Public Health
3
FDA Approves CytoCell CDx for Revumenib in KMT2A-Mutant Acute Leukemia
4
Respiratory Health Risks Linked to Chemical Cleaners and Biomass Fuel in Homes
5